Announcement on the Start of Clinical Trials for Medical Devices Utilizing Our Voice Analysis Algorithm
PST Inc. (CEO: Hiroshi Otsuka) and Sekisui Chemical Co., Ltd. (CEO: Keita Kato) are developing a voice analysis algorithm for cognitive function screening.
We are pleased to announce that Sekisui Chemical has announced that preparations for clinical trials of a cognitive function testing device utilizing the above algorithm have been completed.
For more details, please refer to the following link:
https://www.sekisui.co.jp/news/2024/1403627_41090.html